Jin‐Tai Yu

Active 1992–2026

Also published as
Jin-Tai Yu
361
Papers
34,280
Citations
104
h-index
332
i10-index

Citations

Citations per year for Jin‐Tai Yu1987: 1 citations1993: 6 citations1994: 2 citations1995: 3 citations1996: 8 citations1997: 7 citations1998: 8 citations1999: 8 citations2000: 10 citations2001: 10 citations2002: 12 citations2003: 11 citations2004: 20 citations2005: 15 citations2006: 11 citations2007: 18 citations2008: 12 citations2009: 11 citations2010: 15 citations2011: 12 citations2012: 16 citations2013: 50 citations2014: 183 citations2015: 250 citations2016: 322 citations2017: 342 citations2018: 406 citations2019: 1,137 citations2020: 1,424 citations2021: 1,641 citations2022: 1,615 citations2023: 1,553 citations2024: 2,604 citations2025: 1,547 citations2026: 80 citations1988–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,463 citing papers, 19% of this breakdownUnited States: 3,441 citing papers, 18.9% of this breakdownUnited Kingdom: 1,234 citing papers, 6.8% of this breakdownItaly: 716 citing papers, 3.9% of this breakdownGermany: 655 citing papers, 3.6% of this breakdownAustralia: 598 citing papers, 3.3% of this breakdownIndia: 587 citing papers, 3.2% of this breakdownCanada: 552 citing papers, 3% of this breakdownSpain: 536 citing papers, 3% of this breakdownSweden: 454 citing papers, 2.5% of this breakdownSouth Korea: 408 citing papers, 2.3% of this breakdownFrance: 405 citing papers, 2.2% of this breakdown
0%19%Other 28.3%

Fields

  • Medicine54.2%
  • Biochemistry, Genetics and Molecular Biology18.5%
  • Neuroscience17.6%
  • Psychology1.7%
  • Immunology and Microbiology1.4%
  • Environmental Science1.1%
  • Other5.5%

Topics

  • Alzheimer's disease research and treatments10.4%
  • Dementia and Cognitive Impairment Research6.9%
  • Neuroinflammation and Neurodegeneration Mechanisms5.2%
  • Tryptophan and brain disorders2.7%
  • Parkinson's Disease Mechanisms and Treatments2.2%
  • Neurological Disease Mechanisms and Treatments2.2%
  • Other70.4%

Coauthors

All papers

Open in search
  1. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.

    Authors: , , , - 2015 cited by 1,301

  2. Plasma proteomic profiles predict future dementia in healthy adults

    Authors: , , , , , , , , , , - Nature Aging 2024 cited by 259

  3. Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies

    Authors: , , , , , , - Ageing Research Reviews 2019 cited by 705

  4. Tauopathies: new perspectives and challenges

    Authors: , , , , - Molecular Neurodegeneration 2022 cited by 305

  5. The Prevalence of Dementia: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , - Journal of Alzheimer s Disease 2019 cited by 545

  6. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

    Authors: , , , , , , , , , , , , - Journal of Affective Disorders 2015 cited by 924

  7. Blood Pressure and Risks of Cognitive Impairment and Dementia

    Authors: , , , , , , , - Hypertension 2020 cited by 396

  8. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease

    Authors: , , , , , , , , , - Alzheimer s & Dementia 2024 cited by 215

  9. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2020 cited by 487

  10. Meta-analysis of modifiable risk factors for Alzheimer's disease

    Authors: , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2015 cited by 579

  11. Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies

    Authors: , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2019 cited by 400

  12. Post-stroke cognitive impairment: epidemiology, mechanisms and management.

    Authors: , , - 2014 cited by 692

  13. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies

    Authors: , , , , , , , , - Neuroscience & Biobehavioral Reviews 2020 cited by 277

  14. Socioeconomic Status and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 39 Prospective Studies

    Authors: , , , , , , - The Journal of Prevention of Alzheimer s Disease 2022 cited by 162

  15. Plasma proteomic profiles predict individual future health risk

    Authors: , , , , , , , - Nature Communications 2023 cited by 140

  16. Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies

    Authors: , , , , , - Current Alzheimer Research 2018 cited by 304

  17. Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies

    Authors: , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2015 cited by 372

  18. Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer’s disease

    Authors: , , , , , , - Cell Death and Disease 2014 cited by 350

  19. The brain structure and genetic mechanisms underlying the nonlinear association between sleep duration, cognition and mental health

    Authors: , , , , , , , , , - Nature Aging 2022 cited by 169

  20. Atlas of the plasma proteome in health and disease in 53,026 adults

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2024 cited by 274

  21. Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management

    Authors: , , , , , , , , , - Journal of Alzheimer s Disease 2022 cited by 201

  22. Association of body mass index with risk of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies

    Authors: , , , , , , , , - Neuroscience & Biobehavioral Reviews 2020 cited by 222

  23. The dynamics of plasma biomarkers across the Alzheimer’s continuum

    Authors: , , , , , , , , , , - Alzheimer s Research & Therapy 2023 cited by 90

  24. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

    Authors: , , , , , - The Lancet Neurology 2017 cited by 472